Copyright Reports & Markets. All rights reserved.

Global Sleep Disorder Therapies Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Sleep Disorder Therapies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Insomnia
      • 1.4.3 Excessive Sleep
      • 1.4.4 Disturbed Sleep
    • 1.5 Market by Application
      • 1.5.1 Global Sleep Disorder Therapies Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Online Pharmacies
      • 1.5.4 Retail Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Sleep Disorder Therapies Market Size
    • 2.2 Sleep Disorder Therapies Growth Trends by Regions
      • 2.2.1 Sleep Disorder Therapies Market Size by Regions (2014-2025)
      • 2.2.2 Sleep Disorder Therapies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Sleep Disorder Therapies Market Size by Manufacturers
      • 3.1.1 Global Sleep Disorder Therapies Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Sleep Disorder Therapies Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Sleep Disorder Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.2 Sleep Disorder Therapies Key Players Head office and Area Served
    • 3.3 Key Players Sleep Disorder Therapies Product/Solution/Service
    • 3.4 Date of Enter into Sleep Disorder Therapies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Sleep Disorder Therapies Market Size by Type (2014-2019)
    • 4.2 Global Sleep Disorder Therapies Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Sleep Disorder Therapies Market Size (2014-2019)
    • 5.2 Sleep Disorder Therapies Key Players in United States
    • 5.3 United States Sleep Disorder Therapies Market Size by Type
    • 5.4 United States Sleep Disorder Therapies Market Size by Application

    6 Europe

    • 6.1 Europe Sleep Disorder Therapies Market Size (2014-2019)
    • 6.2 Sleep Disorder Therapies Key Players in Europe
    • 6.3 Europe Sleep Disorder Therapies Market Size by Type
    • 6.4 Europe Sleep Disorder Therapies Market Size by Application

    7 China

    • 7.1 China Sleep Disorder Therapies Market Size (2014-2019)
    • 7.2 Sleep Disorder Therapies Key Players in China
    • 7.3 China Sleep Disorder Therapies Market Size by Type
    • 7.4 China Sleep Disorder Therapies Market Size by Application

    8 Japan

    • 8.1 Japan Sleep Disorder Therapies Market Size (2014-2019)
    • 8.2 Sleep Disorder Therapies Key Players in Japan
    • 8.3 Japan Sleep Disorder Therapies Market Size by Type
    • 8.4 Japan Sleep Disorder Therapies Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Sleep Disorder Therapies Market Size (2014-2019)
    • 9.2 Sleep Disorder Therapies Key Players in Southeast Asia
    • 9.3 Southeast Asia Sleep Disorder Therapies Market Size by Type
    • 9.4 Southeast Asia Sleep Disorder Therapies Market Size by Application

    10 India

    • 10.1 India Sleep Disorder Therapies Market Size (2014-2019)
    • 10.2 Sleep Disorder Therapies Key Players in India
    • 10.3 India Sleep Disorder Therapies Market Size by Type
    • 10.4 India Sleep Disorder Therapies Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Sleep Disorder Therapies Market Size (2014-2019)
    • 11.2 Sleep Disorder Therapies Key Players in Central & South America
    • 11.3 Central & South America Sleep Disorder Therapies Market Size by Type
    • 11.4 Central & South America Sleep Disorder Therapies Market Size by Application

    12 International Players Profiles

    • 12.1 Sanofi
      • 12.1.1 Sanofi Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Sleep Disorder Therapies Introduction
      • 12.1.4 Sanofi Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.1.5 Sanofi Recent Development
    • 12.2 Phillips Healthcare
      • 12.2.1 Phillips Healthcare Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Sleep Disorder Therapies Introduction
      • 12.2.4 Phillips Healthcare Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.2.5 Phillips Healthcare Recent Development
    • 12.3 Nox Medical
      • 12.3.1 Nox Medical Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Sleep Disorder Therapies Introduction
      • 12.3.4 Nox Medical Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.3.5 Nox Medical Recent Development
    • 12.4 Fisher and Paykel Healthcare
      • 12.4.1 Fisher and Paykel Healthcare Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Sleep Disorder Therapies Introduction
      • 12.4.4 Fisher and Paykel Healthcare Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.4.5 Fisher and Paykel Healthcare Recent Development
    • 12.5 Responsive Surface Technology
      • 12.5.1 Responsive Surface Technology Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Sleep Disorder Therapies Introduction
      • 12.5.4 Responsive Surface Technology Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.5.5 Responsive Surface Technology Recent Development
    • 12.6 Eight Sleep
      • 12.6.1 Eight Sleep Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Sleep Disorder Therapies Introduction
      • 12.6.4 Eight Sleep Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.6.5 Eight Sleep Recent Development
    • 12.7 Sleep Number
      • 12.7.1 Sleep Number Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Sleep Disorder Therapies Introduction
      • 12.7.4 Sleep Number Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.7.5 Sleep Number Recent Development
    • 12.8 Vanda Pharmaceuticals
      • 12.8.1 Vanda Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Sleep Disorder Therapies Introduction
      • 12.8.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.8.5 Vanda Pharmaceuticals Recent Development
    • 12.9 Eli Lilly
      • 12.9.1 Eli Lilly Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Sleep Disorder Therapies Introduction
      • 12.9.4 Eli Lilly Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.9.5 Eli Lilly Recent Development
    • 12.10 Neurim Pharmaceuticals
      • 12.10.1 Neurim Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Sleep Disorder Therapies Introduction
      • 12.10.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2014-2019)
      • 12.10.5 Neurim Pharmaceuticals Recent Development
    • 12.11 Merck

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime.
      In 2018, the global Sleep Disorder Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Sleep Disorder Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sleep Disorder Therapies development in United States, Europe and China.

      The key players covered in this study
      Sanofi
      Phillips Healthcare
      Nox Medical
      Fisher and Paykel Healthcare
      Responsive Surface Technology
      Eight Sleep
      Sleep Number
      Vanda Pharmaceuticals
      Eli Lilly
      Neurim Pharmaceuticals
      Merck

      Market segment by Type, the product can be split into
      Insomnia
      Excessive Sleep
      Disturbed Sleep

      Market segment by Application, split into
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Sleep Disorder Therapies status, future forecast, growth opportunity, key market and key players.
      To present the Sleep Disorder Therapies development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Sleep Disorder Therapies are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now